This site is intended for healthcare professionals only
LoginRegister
Modernas Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales SlumpModerna's Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales Slump
West Pharmas 2025 Forecast Misses Estimates as Inventory Reductions ContinueWest Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanRetinal examination be done at each visit: CDSCO Panel tells Alkem Lab on Semaglutide Injection...
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsZydus' Ambernath API Plant Clears USFDA Inspection with Zero Observations
AIMSS Infrastructure Delays Trigger HP High Court WarningCourt Relief: Pharma MD Gets Bail After 22-Month Jail In Tramadol Smuggling Case
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataUS Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome CaseSetback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case
RocheUSFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy
NPPA Sets New Retail Price for Cilnidipine, Telmisartan CombinationNPPA Sets New Retail Price for Cilnidipine, Telmisartan Combination
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Medicare Gets CDSCO Panel Nod for Novel NAFLD Drug, Advances to Marketing Approval Stage
Natco Pharma unveils Everolimus tablets 1mg in USNatco Pharma Q3 Profit Falls 38% to Rs132 Cr Amid Formulation Export Slump
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataGlenmark Rolls Out Generic Xalatan in US, Targets USD 113M Market
X